InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Steinman Lawrence, Director. Insider active across 3 companies, notably BioAtla, Inc.. In total, 24 reports have been logged. Breakdown: 5 buys · 4 sells. Total volume traded: €231k. Activity tracked since 14 June 2021. The latest transaction was disclosed on 28 November 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Steinman Lawrence
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
133,333 shares@ US$0.7567.0% of flowCommon StockSEC:0001213900-25-116309:0
Canonical exit: 26 Feb 2026 (T+90)
44,959 shares0Common StockSEC:0001213900-25-059798:0
48,198 shares0Common StockSEC:0001213900-25-056269:0
23,500 shares0Common StockSEC:0000950170-25-088063:0
65,000 shares0Common StockSEC:0001213900-25-016193:0
16,500 shares0Common StockSEC:0000950170-24-073675:0
20,000 shares@ US$2.052425.2% of flowCommon StockSEC:0001209191-23-059284:0
Canonical exit: 18 Mar 2024 (T+90)
30,000 shares@ US$0.43128.3% of flowCommon StockSEC:0001493152-23-020333:0
Canonical exit: 31 Aug 2023 (T+90)
18,000 shares@ US$1.22618.3% of flowCommon StockSEC:0001213900-23-045386:0
Canonical exit: 30 Aug 2023 (T+90)
5,000 shares@ US$0.9811.1% of flowCommon StockSEC:0001213900-22-075491:0
5,000 shares@ US$0.9911.4% of flowCommon StockSEC:0001213900-22-074585:0
5,000 shares@ US$1.1012.8% of flowCommon StockSEC:0001213900-22-066554:0
1,000 shares@ US$1.142.7% of flowCommon StockSEC:0001213900-22-064401:0
5,000 shares@ US$1.0250.5% of flowCommon StockSEC:0001213900-22-036296:0
5,000 shares@ US$1.0011.1% of flowCommon StockSEC:0001213900-22-035201:0
5,000 shares@ US$1.0049.5% of flowCommon StockSEC:0001213900-22-034621:0
652,174 shares0Common StockSEC:0001213900-22-034366:0
5,000 shares@ US$4.2728.4% of flowCommon StockSEC:0001213900-21-064570:0
Canonical exit: 9 Mar 2022 (T+90)
450 shares@ US$30.0012.5% of flowCommon StockSEC:0001209191-21-062747:0
5,216 shares@ US$6.0040.7% of flowCommon StockSEC:0001013762-21-000203:0
450 shares@ US$36.8215.0% of flowCommon StockSEC:0001209191-21-056574:0
450 shares@ US$40.6016.6% of flowCommon StockSEC:0001209191-21-052295:0
450 shares@ US$38.2915.6% of flowCommon StockSEC:0001209191-21-047324:0
5,388 shares0Common StockSEC:0001209191-21-041216:0
24 of 24 declarations
About Steinman Lawrence
STEINMAN LAWRENCE is Administrateur at Pasithea Therapeutics Corp., BioAtla, Inc. and 180 Life Sciences Corp. He has 24 filings in total, and across the 24 sampled filings between 2021-06-16 and 2025-12-01, buys amount to EUR 175126 and sells to EUR 55753, with a modal transaction nature of Attribution.
